Guardian Pharmacy Services (NYSE:GRDN) Posts Earnings Results

Guardian Pharmacy Services (NYSE:GRDN) released its earnings results on Tuesday. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19), Zacks reports. The firm had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. Guardian Pharmacy Services updated its FY 2024 guidance to EPS.

Guardian Pharmacy Services Price Performance

Shares of NYSE:GRDN traded up $0.79 on Friday, reaching $21.79. 15,178 shares of the company’s stock were exchanged, compared to its average volume of 155,530. Guardian Pharmacy Services has a fifty-two week low of $14.16 and a fifty-two week high of $23.05.

Analyst Upgrades and Downgrades

A number of research firms have commented on GRDN. Raymond James initiated coverage on shares of Guardian Pharmacy Services in a research note on Monday, October 21st. They set an “outperform” rating and a $21.00 price objective on the stock. Truist Financial lifted their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Stephens began coverage on Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 price objective on the stock.

Insider Transactions at Guardian Pharmacy Services

In related news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were acquired at an average price of $14.00 per share, with a total value of $499,996.00. Following the acquisition, the director now owns 35,714 shares in the company, valued at approximately $499,996. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.